Antiarrhythmic mechanisms of beta blocker therapy

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Sympathetic activity plays an important role in modulation of cardiac rhythm. Indeed, while exerting positive tropic effects in response to physiologic and pathologic stressors, β-adrenergic stimulation influences cardiac electrophysiology and can lead to disturbances of the heart rhythm and potentially lethal arrhythmias, particularly in pathological settings. For this reason, β-blockers are widely utilized clinically as antiarrhythmics. In this review, the molecular mechanisms of β-adrenergic action in the heart, the cellular and tissue level cardiac responses to β-adrenergic stimulation, and the clinical use of β-blockers as antiarrhythmic agents are reviewed. We emphasize the complex interaction between cardiomyocyte signaling, contraction, and electrophysiology occurring over multiple time- and spatial-scales during pathophysiological responses to β-adrenergic stimulation. An integrated understanding of this complex system is essential for optimizing therapies aimed at preventing arrhythmias.

Original languageEnglish (US)
Article number104274
JournalPharmacological Research
Volume146
DOIs
StatePublished - Aug 1 2019

Fingerprint

Adrenergic Agents
Cardiac Arrhythmias
Cardiac Electrophysiology
Electrophysiology
Therapeutics
Cardiac Myocytes

Keywords

  • Arrhythmia
  • Autonomic drugs
  • Beta-blockers
  • Heart failure
  • Sympathetic stimulation

ASJC Scopus subject areas

  • Pharmacology

Cite this

Antiarrhythmic mechanisms of beta blocker therapy. / Grandi, Eleonora; Ripplinger, Crystal M.

In: Pharmacological Research, Vol. 146, 104274, 01.08.2019.

Research output: Contribution to journalReview article

@article{a25cdea2109b4eaca0124b02c3e0564a,
title = "Antiarrhythmic mechanisms of beta blocker therapy",
abstract = "Sympathetic activity plays an important role in modulation of cardiac rhythm. Indeed, while exerting positive tropic effects in response to physiologic and pathologic stressors, β-adrenergic stimulation influences cardiac electrophysiology and can lead to disturbances of the heart rhythm and potentially lethal arrhythmias, particularly in pathological settings. For this reason, β-blockers are widely utilized clinically as antiarrhythmics. In this review, the molecular mechanisms of β-adrenergic action in the heart, the cellular and tissue level cardiac responses to β-adrenergic stimulation, and the clinical use of β-blockers as antiarrhythmic agents are reviewed. We emphasize the complex interaction between cardiomyocyte signaling, contraction, and electrophysiology occurring over multiple time- and spatial-scales during pathophysiological responses to β-adrenergic stimulation. An integrated understanding of this complex system is essential for optimizing therapies aimed at preventing arrhythmias.",
keywords = "Arrhythmia, Autonomic drugs, Beta-blockers, Heart failure, Sympathetic stimulation",
author = "Eleonora Grandi and Ripplinger, {Crystal M}",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.phrs.2019.104274",
language = "English (US)",
volume = "146",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Antiarrhythmic mechanisms of beta blocker therapy

AU - Grandi, Eleonora

AU - Ripplinger, Crystal M

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Sympathetic activity plays an important role in modulation of cardiac rhythm. Indeed, while exerting positive tropic effects in response to physiologic and pathologic stressors, β-adrenergic stimulation influences cardiac electrophysiology and can lead to disturbances of the heart rhythm and potentially lethal arrhythmias, particularly in pathological settings. For this reason, β-blockers are widely utilized clinically as antiarrhythmics. In this review, the molecular mechanisms of β-adrenergic action in the heart, the cellular and tissue level cardiac responses to β-adrenergic stimulation, and the clinical use of β-blockers as antiarrhythmic agents are reviewed. We emphasize the complex interaction between cardiomyocyte signaling, contraction, and electrophysiology occurring over multiple time- and spatial-scales during pathophysiological responses to β-adrenergic stimulation. An integrated understanding of this complex system is essential for optimizing therapies aimed at preventing arrhythmias.

AB - Sympathetic activity plays an important role in modulation of cardiac rhythm. Indeed, while exerting positive tropic effects in response to physiologic and pathologic stressors, β-adrenergic stimulation influences cardiac electrophysiology and can lead to disturbances of the heart rhythm and potentially lethal arrhythmias, particularly in pathological settings. For this reason, β-blockers are widely utilized clinically as antiarrhythmics. In this review, the molecular mechanisms of β-adrenergic action in the heart, the cellular and tissue level cardiac responses to β-adrenergic stimulation, and the clinical use of β-blockers as antiarrhythmic agents are reviewed. We emphasize the complex interaction between cardiomyocyte signaling, contraction, and electrophysiology occurring over multiple time- and spatial-scales during pathophysiological responses to β-adrenergic stimulation. An integrated understanding of this complex system is essential for optimizing therapies aimed at preventing arrhythmias.

KW - Arrhythmia

KW - Autonomic drugs

KW - Beta-blockers

KW - Heart failure

KW - Sympathetic stimulation

UR - http://www.scopus.com/inward/record.url?scp=85066794768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066794768&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2019.104274

DO - 10.1016/j.phrs.2019.104274

M3 - Review article

VL - 146

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

M1 - 104274

ER -